Pérez R - Search Results

1

Tumor-specific immunotherapy based on dominant models of natural tolerance.

Montero E, Amador JF, Pérez R, Lage A. Montero E, et al. Among authors: perez r. Med Hypotheses. 2000 Apr;54(4):531-6. doi: 10.1054/mehy.1999.0892. Med Hypotheses. 2000. PMID: 10859636

2

Interleukin-2 mastering regulation in cancer and autoimmunity.

Montero E, Alonso L, Perez R, Lage A. Montero E, et al. Among authors: perez r. Ann N Y Acad Sci. 2007 Jun;1107:239-50. doi: 10.1196/annals.1381.026. Ann N Y Acad Sci. 2007. PMID: 17804552

3

Chemotherapy induced transient B-cell depletion boosts antibody-forming cells expansion driven by an epidermal growth factor-based cancer vaccine.

Montero E, Valdes M, Avellanet J, Lopez A, Perez R, Lage A. Montero E, et al. Among authors: perez r. Vaccine. 2009 Apr 6;27(16):2230-9. doi: 10.1016/j.vaccine.2009.02.018. Epub 2009 Feb 13. Vaccine. 2009. PMID: 19428837

4

Natural and induced tolerance in an immune network model.

León K, Carneiro J, Peréz R, Montero E, Lage A. León K, et al. Among authors: perez r. J Theor Biol. 1998 Aug 7;193(3):519-34. doi: 10.1006/jtbi.1998.0720. J Theor Biol. 1998. PMID: 9735278

5

Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates.

León K, Peréz R, Lage A, Carneiro J. León K, et al. Among authors: perez r. J Theor Biol. 2000 Nov 21;207(2):231-54. doi: 10.1006/jtbi.2000.2169. J Theor Biol. 2000. PMID: 11034831

6

Therapeutic cancer vaccines: at midway between immunology and pharmacology.

Lage A, Perez R, Fernandez LE. Lage A, et al. Among authors: perez r. Curr Cancer Drug Targets. 2005 Dec;5(8):611-27. doi: 10.2174/156800905774932789. Curr Cancer Drug Targets. 2005. PMID: 16375666 Review.

7

Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model.

Fuentes D, Avellanet J, Garcia A, Iglesias N, Gabri MR, Alonso DF, Vazquez AM, Perez R, Montero E. Fuentes D, et al. Among authors: perez r. Breast Cancer Res Treat. 2010 Apr;120(2):379-89. doi: 10.1007/s10549-009-0399-9. Epub 2009 Apr 18. Breast Cancer Res Treat. 2010. PMID: 19377876

8

Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies.

Montero E, Nussbaum G, Kaye JF, Perez R, Lage A, Ben-Nun A, Cohen IR. Montero E, et al. Among authors: perez r. J Autoimmun. 2004 Aug;23(1):1-7. doi: 10.1016/j.jaut.2004.05.001. J Autoimmun. 2004. PMID: 15236747

9

Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine.

Rodriguez PC, Gonzalez I, Gonzalez A, Avellanet J, Lopez A, Perez R, Lage A, Montero E. Rodriguez PC, et al. Among authors: perez r. Vaccine. 2008 Aug 26;26(36):4647-54. doi: 10.1016/j.vaccine.2008.07.003. Epub 2008 Jul 18. Vaccine. 2008. PMID: 18640164

10

Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).

Macias A, Arce S, Leon J, Mustelier G, Bombino G, Domarco A, Perez R, Lage A. Macias A, et al. Among authors: perez r. Hybridoma. 1999 Jun;18(3):263-72. doi: 10.1089/027245799315925. Hybridoma. 1999. PMID: 10475241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,967 results

Search Page

Filters